1 ML secukinumab 150 MG/ML Prefilled Syringe — RxCUI 1599792
RxNorm drug concept · Semantic clinical drug
RxCUI 1599792
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1599792
Official name1 ML secukinumab 150 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assecukinumab 150 MG/ML 1ML Prefilled Syringe; secukinumab 150 MG in 1 ML Prefilled Syringe
FDA products mapped4
Package NDCs mapped9
Reported Medicaid activity (SDUD)149,840 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Secukinumab Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Cosentyx is a biologic injection approved for several inflammatory conditions: moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic ax...
- What exactly is Cosentyx used for — and is it right for me?
- Most people take Cosentyx as a subcutaneous injection — meaning a small shot under the skin, usually in the thigh, abdomen, or upper arm. You'll typically start with weekly injecti...
- How do I take Cosentyx, and can I do it myself at home?
🕸️ Concept Web — How 1 ML secukinumab 150 MG/ML Prefilled Syringe Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
1 ML secukinumab 150 MG/ML Prefilled Syringe
RxCUI 1599792 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Secukinumab
1599788IN
-
Secukinumab
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cosentyx
1599793BN
-
Cosentyx
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Secukinumab Prefilled Syringe
1599791SCDF -
Secukinumab Injectable Product
1599790SCDG -
Secukinumab Prefilled Syringe [Cosentyx]
1599795SBDF -
Cosentyx Injectable Product
1599796SBDG -
Prefilled Syringe
721656DF -
Injectable Product
1151126DFG
-
Secukinumab Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Secukinumab 150 MG/ML
1599789SCDC -
1 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx]
1599797SBD -
Secukinumab 150 MG/ML [Cosentyx]
1599794SBDC
-
Secukinumab 150 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Secukinumab 150 MG/ML
SCDC · 1599789 -
Secukinumab Prefilled Syringe
SCDF · 1599791 -
Secukinumab Injectable Product
SCDG · 1599790
Brand-Name Concepts
-
1 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx]
SBD · 1599797 -
Secukinumab 150 MG/ML [Cosentyx]
SBDC · 1599794 -
Secukinumab Prefilled Syringe [Cosentyx]
SBDF · 1599795 -
Cosentyx Injectable Product
SBDG · 1599796 -
Cosentyx
BN · 1599793
📦 FDA Products & Package NDCs
4 products · 9 package NDCs
9 package NDCs map to RxCUI 1599792 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0639-41 | 2 mL in 1 CARTON (0078-0639-41) | COSENTYX | Novartis Pharmaceuticals Corporation | 2015-01-21 |
| 00078-0639-68 | 1 mL in 1 CARTON (0078-0639-68) | COSENTYX | Novartis Pharmaceuticals Corporation | 2015-01-21 |
| 00078-0639-97 | 1 mL in 1 CARTON (0078-0639-97) | COSENTYX | Novartis Pharmaceuticals Corporation | 2015-01-21 |
| 00078-0639-98 | 2 mL in 1 CARTON (0078-0639-98) | COSENTYX | Novartis Pharmaceuticals Corporation | 2015-01-21 |
| 00078-1056-97 | 1 SYRINGE, GLASS in 1 CARTON (0078-1056-97) / .5 mL in 1 SY... | COSENTYX | Novartis Pharmaceuticals Corporation | 2021-05-28 |
| 00078-1056-99 | 1 SYRINGE, GLASS in 1 CARTON (0078-1056-99) / .5 mL in 1 SY... | COSENTYX | Novartis Pharmaceuticals Corporation | 2021-05-28 |
| 00078-1070-68 | 1 SYRINGE, GLASS in 1 CARTON (0078-1070-68) / 2 mL in 1 SYR... | COSENTYX | Novartis Pharmaceuticals Corporation | 2023-05-11 |
| 00078-1070-96 | 1 SYRINGE, GLASS in 1 CARTON (0078-1070-96) / 2 mL in 1 SYR... | COSENTYX | Novartis Pharmaceuticals Corporation | 2023-05-11 |
| 00078-1168-61 | 5 mL in 1 VIAL, GLASS (0078-1168-61) | COSENTYX | Novartis Pharmaceuticals Corporation | 2023-10-06 |
Observed labelers:
Novartis Pharmaceuticals Corporation (9)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3247 | Inj secukinumab intrav 1mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.